PRESS RELEASE published on 01/28/2025 at 14:14, 1 year 7 months ago Inside Information / Other news releases Arkema discloses trading in own shares from 20 to 23 January 2025, totaling 16,000 shares bought back. Details available on Arkema's investor relations website Share Buyback Investor Relations Trading 2025 ARKEMA
PRESS RELEASE published on 01/28/2025 at 14:14, 1 year 7 months ago Informations privilégiées / Autres communiqués Arkema annonce avoir effectué des achats d'actions propres conformément à la réglementation. Les détails des transactions sont disponibles sur leur site internet Actions Propres Rachat D'actions Transactions Site Internet ARKEMA
BRIEF published on 01/27/2025 at 09:47, 1 year 7 months ago BlackRock dépasse le seuil de 5% du capital d'ARKEMA Capital Franchissement De Seuil Actions BlackRock ARKEMA
BRIEF published on 01/27/2025 at 09:47, 1 year 7 months ago BlackRock exceeds the 5% threshold of ARKEMA's capital Capital Actions BlackRock Threshold Crossing ARKEMA
PRESS RELEASE published on 01/27/2025 at 09:42, 1 year 7 months ago Franchissement de seuil Déclaration de franchissement de seuil par BlackRock Inc. pour le compte de clients et de fonds détenant 5,36% du capital d'ARKEMA Franchissement De Seuil BlackRock Inc. Acquisition Actions ARKEMA Gestionnaire D'investissement
BRIEF published on 01/21/2025 at 15:47, 1 year 7 months ago Arkema Carries Out Share Buybacks from January 13 to 17, 2025 Transactions Share Buyback Financial Market Regulation EU 596/2014 ARKEMA
BRIEF published on 01/21/2025 at 15:47, 1 year 7 months ago Arkema procède à des rachats d'actions du 13 au 17 janvier 2025 Marché Financier Rachat D'actions Transactions ARKEMA Règlement UE 596/2014
PRESS RELEASE published on 01/21/2025 at 15:42, 1 year 7 months ago Inside Information / Other news releases Arkema discloses share buyback transactions for own shares from 13 to 17 January 2025 in compliance with regulations. Total daily volume: 17,500 shares. Weighted average price: 72,9529. More details on Arkema's website Trading Disclosure Share Buyback Investor Relations Regulation Compliance ARKEMA
PRESS RELEASE published on 01/21/2025 at 15:42, 1 year 7 months ago Informations privilégiées / Autres communiqués Arkema déclare avoir acheté 17 500 actions propres entre le 13 janvier et le 17 janvier 2025, conformément à la réglementation en vigueur Actions Propres Rachat D'actions Transactions Réglementation ARKEMA
BRIEF published on 01/14/2025 at 16:02, 1 year 7 months ago Arkema déclare ses transactions sur actions propres de janvier 2025 XPAR Achat D'actions Prix Moyen ARKEMA Janvier 2025
Published on 09/11/2026 at 04:00, 7 hours 43 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 13 hours 18 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 20 hours 23 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 20 hours 43 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 11:35, 8 minutes ago EQS-Adhoc: Correction of a release from 10/09/2026, 19:35 CET/CEST - United Internet AG: Group subsidiaries 1&1 AG and IONOS Group SE launch transformation programs
Published on 09/11/2026 at 11:30, 13 minutes ago Galimedix Therapeutics to present functional feasibility data from Phase 2 eDREAM study in geographic atrophy at 26th EURETINA Congress
Published on 09/11/2026 at 10:15, 1 hour 28 minutes ago TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
Published on 09/11/2026 at 09:20, 2 hours 23 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 2 hours 38 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 07:00, 4 hours 43 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 4 hours 43 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 4 hours 43 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 16 hours 13 minutes ago Availability of the 2026 Interim Financial Report
